NEW YORK, March 6, 2025 /PRNewswire/ — ProofPilot, the leading Clinical Experience Platform (CXP), today announced they will host a panel session at the upcoming Patients as Partners conference in Boston on March 18. The session, titled “Incorporating Patient Input When It Counts: At the Beginning” will explore actionable strategies for integrating patient feedback into multiple touchpoints across clinical trials.
The panel, featuring representatives of two pharma Sponsors and a leading patient advocate, will offer diverse perspectives as they explore best practices for gathering and incorporating patient input on public-facing clinical trial finders, eDiaries, protocols, and more.
Session Details
Title: Incorporating Patient Input When It Counts: At the Beginning
Date & Time: March 18, 2025, 2:55 pm ET
Panelists:
“We often discuss the ‘why’ of patient input, but the ‘how’ and the ‘when’ are just as critical to a study’s success,” said Chris Venezia, CEO of ProofPilot. “At Patients as Partners this year, we’ll bring the patient and the sponsors together to explore real strategies for capturing and incorporating patient feedback throughout the study.”
ProofPilot looks forward to hosting an insightful conversation around this strong strategy for putting the patient at the center of the user experience.
About ProofPilot
ProofPilot is the industry’s first end-to-end Clinical Experience Platform, purpose-built for recruitment and engagement for all study stakeholders. Made up of highly experienced professionals from all facets of the clinical research and health tech industry, ProofPilot leverages this collective wisdom to deliver powerful solutions that have continued to plague the industry for decades. Learn more at https://www.proofpilot.com.
Stay informed about ProofPilot news at https://www.linkedin.com/company/proofpilot
Media Contact: Hope McCain, hope.mccain@proofpilot.com
SOURCE ProofPilot
CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…
PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…